Fabrication of polyelectrolyte multilayered vesicles as inhalable dry powder for lung administration of rifampicin

International Journal of Pharmaceutics

Volumn 472, Issue 1-2, 2014, Pages 102-109

  Manca, Maria Letizia ^a   Valenti, Donatella ^a   Sales, Octavio Diez ^b   Nacher, Amparo ^b   Fadda, Anna Maria ^a   Manconi, Maria ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Carrageenan; Chitosan; Coated liposomes; Next generation impactor; Pulmonary delivery; Rifampicin

Indexed keywords

LIPOSOME; POLYELECTROLYTE; RIFAMPICIN; CARRAGEENAN; CHITOSAN; TUBERCULOSTATIC AGENT;

AEROSOL; ARTICLE; CELL VIABILITY; COATED VESICLE; CONFOCAL MICROSCOPY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRY POWDER; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; X RAY DIFFRACTION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG FORMULATION; INHALATIONAL DRUG ADMINISTRATION; TUMOR CELL LINE;

ADMINISTRATION, INHALATION; ANTIBIOTICS, ANTITUBERCULAR; CALORIMETRY, DIFFERENTIAL SCANNING; CARRAGEENAN; CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; DRUG COMPOUNDING; HUMANS; LIPOSOMES; PARTICLE SIZE; RIFAMPIN; X-RAY DIFFRACTION;

EID: 84903276420     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.06.009     Document Type: Article

References (37)

1. V.L. Campo, D.F. Kawano, D.B. da Silva Jr, and I. Carvalho Carrageenans: biological properties, chemical modifications and structural analysis - a review Carbohydr. Polym. 77 2009 167 180
2. I. Castangia, M.L. Manca, P. Matricardi, C. Sinico, S. Lampis, X. Fernàndez-Busquets, A.M. Fadda, and M. Manconi Effect of diclofenac and glycol intercalation on structural assembly of phospholipid lamellar vesicles Int. J. Pharm. 456 2013 1 9
3. N. Changsan, H.K. Chan, F. Separovic, and T. Srichana Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation J. Pharm. Sci. 98 2009 628 639
4. I. Coowanitwong, V. Arya, P. Kulvanich, and G. Hochhaus Slow release formulations of inhaled rifampin AAPS J. 10 2008 342 348
5. G. Corti, M. Cirri, F. Maestrelli, N. Mennini, and P. Mura Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-β-cyclodextrin Eur. J. Pharm. Biopharm. 68 2008 303 309
6. R. De Souza, P. Zahedi, C.J. Allen, and M. Piquette-Miller Biocompatibility of injectable chitosan-phospholipid implant systems Biomaterials 30 2009 3818 3824
7. M.M. Gaspar, U. Bakowsky, and C. Ehrhardt Inhaled liposomescurrent strategies and future challenges J. Biomed. Nanotechnol. 4 2008 245 257
8. A.S. Halim, L.C. Keong, I. Zainol, and A.H.A. Rashid Biocompatibility and Biodegradation of Chitosan and Derivatives, Chitosan-Based Systems for Biopharmaceuticals 2012 John Wiley & Sons, Ltd. Chichester, UK 57 73
9. Y. Kawashima, T. Serigano, T. Hino, H. Yamamoto, and H. Takeuchi Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate Int. J. Pharm. 172 1998 179 188
10. Y.-M. Lim, H.-J. Gwon, J.-H. Choi, J. Shin, Y.-C. Nho, S.I. Jeong, M.S. Chong, Y.-M. Lee, I.K. Kwon, and S.E. Kim Preparation and biocompatibility study of gelatin/kappa-carrageenan scaffolds Macromol. Res. 18 2010 29 34
11. H.S. Mahajan, and S.A. Gundare Preparation, characterization and pulmonary pharmacokinetics of xyloglucan microspheres as dry powder inhalation Carbohydr. Polym. 2013
12. M.L. Manca, G. Loy, M. Zaru, A.M. Fadda, and S.G. Antimisiaris Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles Colloids Surf. B: Biointerfaces 67 2008 166 170
13. M.L. Manca, M. Manconi, D. Valenti, F. Lai, G. Loy, P. Matricardi, and A.M. Fadda Liposomes coated with chitosan-xanthan gum (chitosomes) as potential carriers for pulmonary delivery of rifampicin J. Pharm. Sci. 101 2012 566 575
14. M.L. Manca, R. Cassano, D. Valenti, S. Trombino, T. Ferrarelli, N. Picci, A.M. Fadda, and M. Manconi Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis J. Pharm. Pharmacol. 65 2013 1302 1311
15. M.L. Manca, M. Manconi, A.M. Falchi, I. Castangia, D. Valenti, S. Lampis, and A.M. Fadda Close-packed vesicles for diclofenac skin delivery and fibroblast targeting Colloids Surf. B: Biointerfaces 111 2013 609 617
16. M. Manconi, R. Isola, A.M. Falchi, C. Sinico, and A.M. Fadda Intracellular distribution of fluorescent probes delivered by vesicles of different lipidic composition Colloids Surf. B: Biointerfaces 57 2007 143 151
17. J. Mano, G. Silva, H.S. Azevedo, P. Malafaya, R. Sousa, S. Silva, L. Boesel, J.M. Oliveira, T. Santos, and A. Marques Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends J. Royal Soc. Interface 4 2007 999 1030
18. H.M. Mansour, Y.-S. Rhee, and X. Wu Nanomedicine in pulmonary delivery Int. J. Nanomed. 4 2009 299
19. M.A. Moretton, D.A. Chiappetta, F. Andrade, J. das Neves, D. Ferreira, B. Sarmento, and A. Sosnik Hydrolyzed galactomannan-modified nanoparticles and flower-like polymeric micelles for the active targeting of rifampicin to macrophages J. Biomed. Nanotechnol. 9 2013 1076 1087
20. C. Mura, M. Manconi, D. Valenti, M.L. Manca, O. Diez-Sales, G. Loy, and A.M. Fadda In vitro study of N-succinyl chitosan for targeted delivery of 5-aminosalicylic acid to colon Carbohydr. Polym. 85 2011 578 583
21. S. Mura, H. Hillaireau, J. Nicolas, B. Le Droumaguet, C. Gueutin, S. Zanna, N. Tsapis, and E. Fattal Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3cells Int. J. Nanomed. 6 2011 2591
22. K. Nahar, N. Gupta, R. Gauvin, S. Absar, B. Patel, V. Gupta, A. Khademhosseini, and F. Ahsan In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals Eur. J. Pharm. Sci. 49 2013 805 818
23. C.M. Pilane, and E.F. LaBelle cPLA2 activator peptide, PLAP, increases arachidonic acid release and apoptosis of vascular smooth muscle cells J. Cell Physiol. 198 2004 48 52
24. M. Pinheiro, M. Lúcio, J.L. Lima, and S. Reis Liposomes as drug delivery systems for the treatment of TB Nanomedicine 6 2011 1413 1428
25. U. Pison, T. Welte, M. Giersig, and D.A. Groneberg Nanomedicine for respiratory diseases Eur. J. Pharmacol. 533 2006 341 350
26. S. Rodrigues, A.M. Costa, and A. Grenha Chitosan/carrageenan nanoparticles: effect of cross-linking with tripolyphosphate and charge ratios Carbohydr. Polym. 89 2012 282 289
27. S. Rodrigues, M. Dionísio, C.R. López, and A. Grenha Biocompatibility of chitosan carriers with application in drug delivery J. Funct. Biomater. 3 2012 615 641
28. S. Suarez, P. O'Hara, M. Kazantseva, C.E. Newcomer, R. Hopfer, D.N. McMurray, and A.J. Hickey Airways delivery of rifampicin microparticles for the treatment of tuberculosis J. Antimicrob. Chemother. 48 2001 431 434
29. J.C. Sung, D.J. Padilla, L. Garcia-Contreras, J.L. VerBerkmoes, D. Durbin, C.A. Peloquin, K.J. Elbert, A.J. Hickey, and D.A. Edwards Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery Pharm. Res. 26 2009 1847 1855
30. L.G. Sweeney, Z. Wang, R. Loebenberg, J.P. Wong, C.F. Lange, and W.H. Finlay Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery Int. J. Pharm. 305 2005 180 185
31. M. Taki, C. Marriott, X.-M. Zeng, and G.P. Martin Aerodynamic deposition of combination dry powder inhaler formulations in vitro: a comparison of three impactors Int. J. Pharm. 388 2010 40 51
32. T.T. Thành, Y. Yuguchi, M. Mimura, H. Yasunaga, R. Takano, H. Urakawa, and K. Kajiwara Molecular characteristics and gelling properties of the carrageenan family, 1. Preparation of novel carrageenans and their dilute solution properties Macromol. Chem. Phys. 203 2002 15 23
33. R.K. Verma, A.K. Singh, M. Mohan, A.K. Agrawal, and A. Misra Inhaled therapies for tuberculosis and the relevance of activation of lung macrophages by particulate drug-delivery systems Ther. Deliv. 2 2011 753 768
34. K. Yamada, N. Kamada, M. Odomi, N. Okada, T. Nabe, T. Fujita, S. Kohno, and A. Yamamoto Carrageenans can regulate the pulmonary absorption of antiasthmatic drugs and their retention in the rat lung tissues without any membrane damage Int. J. Pharm. 293 2005 63 72
35. M. Zaru, S. Mourtas, P. Klepetsanis, A.M. Fadda, and S.G. Antimisiaris Liposomes for drug delivery to the lungs by nebulization Eur. J. Pharm. Biopharm. 67 2007 655 666
36. M. Zaru, M.-L. Manca, A.M. Fadda, and S.G. Antimisiaris Chitosan-coated liposomes for delivery to lungs by nebulisation Colloids Surf. B: Biointerfaces 71 2009 88 95
37. M. Zaru, C. Sinico, De Logu, A. Caddeo, C. Lai, F. Manca, M.L. Fadda, and A.M Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation J. Liposome Res. 19 2009 68 76